return equiti ttm
anoth strong quarter across board multipl opportun drive
report anoth strong quarter result fiscal second-quart revenu
million year-over-year ahead street estim
million encouragingli beat driven strength across board continu
momentum shock hrpci continu adopt intern
market especi germani japan despit on-going invest educ
train oper margin also came basi point estim
benefit higher impella volum better gross margin anticip
manag rais low end fiscal revenu guidanc million
million year-over-year versu street prior estim
million million recal rep histor brought
annual train fiscal second quarter end june year tct meet
held septemb manag start hire train rep octob fiscal
third quarter result manag expect step-up fiscal fourth-quart growth
fulli train rep enter field second-half sale histor
rang full-year sale guidanc impli second half fiscal make
full-year sale believ conserv
believ room upsid guidanc given multipl catalyst
push growth higher includ expand high-risk pci hrpci shock indic
manag mention alreadi see benefit ramp rp japanes
sale new train site japan alreadi expect on-going momentum
independ nation cardiogen shock initi new product introduct
optic sensor impella europ
note data compani stemi dtu studi expect present
aha meet sunday novemb manag host confer call next day
monday updat investor regulatori pathway treat stemi popul
result posit could lead larger pivot random control trial
turn could open increment patient popul nearli doubl
compani current identifi address hrpci shock market
bar high quarter given valuat fundament perform
strong believ manag appropri invest busi drive growth
pay comp becom difficult second half fiscal year
share current trade time calendar revenu estim million
believ premium warrant compani oper monopoli
vastli under-penetrated market rate stock outperform
make number cardiac-assist devic treat acut heart failur compani portfolio
highlight impella product first percutan catheter-bas cardiac assist devic
conclus stock thought
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
 quarter recap report anoth strong quarter beat estim million strength
unit state million beat intern million beat growth shock protect pci came
expect manag highlight continu progress education/train initi support long-term
util adopt impella overal result quarter support continu adopt field
drive continu strong top-lin growth
domest sale came million ahead expect driven anoth strong quarter growth
shock fifth quarter row growth hrpci quarter acceler
last quarter comp get difficult shock second half year third
fourth quarter believ number driver capabl support continu momentum
includ hospit ad protocol patient launch rp increas train physician rep
within shock dr oneil tct updat nation csi initi ncsi suggest
site across enrol program treat patient last year patient
surviv discharg reach compar histor surviv rate discharg
patient leav nativ heart reinforc focu nativ heart recoveri
number patient continu grow mani site newer program
manag also highlight data iq commerci databas patient demonstr
surviv rate nation averag percentag center achiev
surviv increas util best practic think data
support clinic benefit impella cardiogen shock patient nativ heart recoveri
data demonstr posit impact invest train educ initi
across countri togeth improv outcom continu train help drive
adopt util impella shock patient
protect pci growth acceler somewhat quarter though manag attribut rep
focu quarter said present number new data set confer relat
reduct acut kidney injuri aki associ use impella high-risk protect pci
patient time drive continu growth potenti expans patient
model domest revenu million fiscal though expect could prove
conserv given tailwind describ launch new product specif abiom
process roll impella connect fiber-opt sensor built pump use
conjunct smartassist monitor patient statu room provid caretak
real-tim nativ cardiac output read addit detail smartassist ndr note
util also see steadi growth averag combin impella cp site inventori
increas unit sequenti believ increas site inventori good futur
indic impella usag exist site expect metric climb higher
sale came million ahead expect driven million beat japan germani
larg line estim increas year-over-year compani continu add
center focu train initi drive util overal believ intern pick
momentum million estim conserv
japan ahead schedul demand impella japan remain high lead strong quarter sale million
million sequenti manag report site current approv
govern center train impella use center sequenti ahead
plan though manag reiter dedic gradual launch japan emphas proper educ
train regionsometh view prudent ensur long-term adopt point manag cite
hospit adopt nci protocol get train pay term util time weve
seen hospit protocol
given better-than-expect progress japan manag updat guidanc japanes sale million
million though still believ could prove conserv compani alreadi report million
year continu add hospit site overal process japan move forward believ countri
even larger sale driver next year new site ramp util size japanes market
 oper margin despit on-going invest compani commerci initi train educ
manufactur abiom deliv strong quarter oper margin beat estim basi point
oper margin basi point year-over-year larg due higher impella sale
continu view manag margin guidanc year achiev particularli first-half
invest posit impact second half typic second-half oper margin come stronger
first half wed assum year driven higher second-half revenu first leverag
sg line percentag total revenu model oper margin fiscal repres basi
point expans fiscal year said estim may well conserv
gross margin came basi point ahead expect basi point year-
over-year gross margin benefit higher volum somewhat off-set continu
manufactur invest support long-term impella suppli gross margin may also see modest headwind
roll-out compani optic sensor cp inventori field swap
also prove transient modest off-set benefit manufactur scale
 pipelin manag reiter expect publish data stemi door-to-unload feasibl studi
american heart associ confer novemb central time result posit
could lead larger pivot trial begin open increment patient popul compani
see revenu million previous million chang larg
account beat quarter
increas ep estim equival beat quarter
see revenu million previous million
increas ep estim
calendar revenu ep estim million
calendar revenu ep estim million
